维普中文期刊产品整合服务
30篇 您的检索式:作者名="Alpaugh RK"
    题名 作者 年代 出处 被引量
1Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma显示文摘Cohen SJ Alpaugh RK Palazzo I 2008Pancreas2008,37,2:1
2Fibroblast activation protein and its relationship to clinical outcome in pancreatic Aden carcinoma 显示文摘Cohen S J Alpaugh RK Palazzo I 2008Pancreas2008,37,2:1
3Superantigen-based immunotherapy: a phase I trial ofPNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer显示文摘Giantonio BJ Alpaugh RK Schultz J 1997J Clin Oncol1997,15,5:1
4Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma显示文摘Cohen SJ Alpaugh RK Palazzo I 2008Pancreas2008,37,2:1
5Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma 显示文摘Cohen SJ Alpaugh RK Palazzo I 2008Pancreas2008,37,2:1
6Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer显示文摘Cohen SJ Alpaugh RK Gross S 2006Clin Colorectal Cancer2006,6,2:1
7Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer显示文摘Cohen SJ Alpaugh RK Gross S 2006Clin Colorectal Cancer2006,6,2:1
8Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer显示文摘Cohen S J Alpaugh RK Gross S 2006Clinical colorectal cancer2006,6,2:1
9Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer显示文摘Cohen SJ Alpaugh RK Gross S 2006Clin Colorectal Cancer2006,6,2:1
10Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcino- ma显示文摘Cohen S J Alpaugh RK Palazzo I 2008Pancreas2008,37,2:1
11Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer显示文摘Cohen SJ Alpaugh RK Gross S 2006Clin Colorectal Cancer2006,6,2:1
12Superantigen-targeted therapy:Phase I escaIating repeat dose trial of the fusion protein PNU-214565 in patients with advanced gastrointestinal malignancies显示文摘Alpaugh RK Schultz J McAleer C 1998Clin Cancer Res1998,4,8:1
13Phase IIand coagulation cascade biomarker study of bevacizumab withor without docetaxel in patients with previously treated meta-static pancreatic adenocarcinoma显示文摘Astsaturov IA Meropol NJ Alpaugh RK 2011Am J Clin Oncol2011,34,:1
14Superantigen-based immunotherapy:A phase I trial of PUN-214565,a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein,in advanced pancreatic and colorectal cancer显示文摘Giantonion BJ Alpaugh RK Schultz J 1997J Clin Oncol1997,15,5:1
15Superantigen-based immunotherapy: a phase I trial of PNU-214565, amonoclonal antibodystaphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer 显示文摘Giantonio B J Alpaugh RK Schuhz J 1997J Clin Onco1997,15,5:1
16Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma显示文摘Cohen SJ Alpaugh RK Palazzo I 2008Pancreas2008,37,2:1
17Superantigen-targeted therapy: phase I escalating repeat dose trial of the fusion protein PNU-214565 in patients with advanced gastrointestinal malignancies 显示文摘 Schultz J McAleer C 1998Clin Cancer Res1998,4,8:1
18Superantigen-targeted therapy: phase I escalating repeat dose trial of the fusion protein PNU-214565 in patients with advanced gastrointestinal malignancies显示文摘ALPAUGH RK SCHULTZ J McALEER C 1998Clin Cancer Res1998,4,8:1
19Superantigen-targeted therapy: phase I escalating repeat dose trial of the fusion protein PNU-214565 in patients with advanced gastrointestinal malignancies显示文摘 Schultz J McAleer C Giantonio BJ Persson R Burnite M Nielsen SE Vitek L Persson B Weiner LM 1998Clin Cancer Res1998,4,8:1
20Fibroblast Activation Protein and Its Relationship to Clinical Outcome in Pancreatic Adenocarcinoma显示文摘Cohen SJ Alpaugh RK Palazzo I 0,,02:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费